Medindia On Mobile
Custom Search

Register
Sign In
Sign In Using Facebook
HOME NEWS HEALTH A-Z HEALTH CENTRES HEALTH TOOLS DIRECTORIES SERVICES WEBSITES BUY ONLINE BLOGS COMMUNITY DOWNLOADS
Home » Corporate News

Memantine Receives Tentative FDA Nod, Says Wockhardt

by Rajshri on  January 07, 2010 at 9:36 PM Corporate News
  •   Print
  •   Share
  •   Comments
  •  Text 
Memantine Receives Tentative FDA Nod, Says Wockhardt
Wockhardt Limited has announced that it has received tentative approval from the US Food and Drug Administration for marketing market Memantine tablets in the strength of 5 mg and 10 mg. Memantine is used in the treatment of Alzheimer`s disease.


The drug works by suppressing N-Methyl-D-Aspartate (NMDA) receptors, which are thought to be responsible for the deterioration of cholinergic cells in the brain.

On December 29, Wockhardt had revealed that its preferential issue would not exceed 1.6 billion convertible or non-convertible redeemable preference shares worth Rs 5 each.



Source-Medindia
RAS

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions 		  

X

Medwonders Health Network

Total Members - 55031
Support Groups - 445
Login  Join Now
Medwonders Health Network
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Senior Health Center

Corporate Related News
» Pfizer Initiates Recall of Birth Control Pills in the US » J&J Initiates Voluntary Recall of Aveeno Baby Lotion
» Fortis to Launch Chain of Dialysis Centers to Broaden Access to Quality Care » Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents
» FDA Approves Abbott’s Xience Prime Coronary Stent » Circadian Technologies’ Investigative Cancer Drug Receives FDA Nod for Clinical Trials
» CooperVision Issues Another Statement Over Contact Lens Recall » Conditional Nod for Proposed Teva Buy
Read More >>
Follow us on : YouTube on Medindia.net Facebook on Medindia.net Twitter on Medindia.net Googleplus on Medindia.net Tumblr on Medindia.net RSS Iphone Digg on Medindia.net Stumbleupon on Medindia.net Delicious on Medindia.net

Consumers

Online Consults Child Health Teen Health Men's Health Women's Health Senior Health Sexual Health Mental Health Dental Health Kidney Health
Diabetes Obesity Vision Care Diet & Nutrition Know Your Body Amazing Body Facts Health Facts Conditions by Specialties Disease FAQs Medical Humour

Medical Professionals

Clinical Tools Health Videos Animation Slides Medical Aphorism Medical Conferences Jobs Journals Web Journals Open Access E-articles
Distance education Doctors Homepage Hospitals Homepage Personalize Info Matrimonial Print Oath Alumni Medical Humour Buy Books

Medical Students

Admissions Medical Colleges Medical Electives Medical Aphorism Post Grad Courses Indian Universities USMLE Centers CGFNS Centers
FRCS in UK PLAB USMLE CGFNS Alumni MCQ Bank Medical Humour Buy Books

Directories

Doctors Hospitals International Hospitals Chemists Surgical Suppliers NGOs Pharmaceuticals Medical Colleges
Home About us Career Sitemap Press Portfolio Advertise Contact Us
Disclaimer - The contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
Advertise with us Medindia Copyright Privacy Policy Terms of Use © All Rights Reserved 1997 - 2012